406 related articles for article (PubMed ID: 10225559)
1. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
2. Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data.
Sanchez-Nieto B; Nahum AE; Dearnaley DP
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):487-99. PubMed ID: 11173145
[TBL] [Abstract][Full Text] [Related]
3. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing.
Bentzen SM
Radiother Oncol; 1997 May; 43(2):121-31. PubMed ID: 9192956
[TBL] [Abstract][Full Text] [Related]
4. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
Paganetti H
Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
[TBL] [Abstract][Full Text] [Related]
5. A method to visualize the uncertainty of the prediction of radiobiological models.
Zhang L; Hub M; Thieke C; Floca RO; Karger CP
Phys Med; 2013 Sep; 29(5):556-61. PubMed ID: 23260766
[TBL] [Abstract][Full Text] [Related]
6. On differences in radiosensitivity estimation: TCP experiments versus survival curves. A theoretical study.
Stavrev P; Stavreva N; Ruggieri R; Nahum A
Phys Med Biol; 2015 Aug; 60(15):N293-9. PubMed ID: 26215150
[TBL] [Abstract][Full Text] [Related]
7. Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck.
Stausbøl-Grøn B; Overgaard J
Radiother Oncol; 1999 Jan; 50(1):47-55. PubMed ID: 10225557
[TBL] [Abstract][Full Text] [Related]
8. In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.
Stausbøl-Grøn B; Bentzen SM; Jørgensen KE; Nielsen OS; Bundgaard T; Overgaard J
Br J Cancer; 1999 Mar; 79(7-8):1074-84. PubMed ID: 10098739
[TBL] [Abstract][Full Text] [Related]
9. Modelling the effect of spread in radiosensitivity parameters and repopulation rate on the probability of tumour control.
Stavreva N; Stavrev P; Balabanova A; Nahum A; Ruggieri R; Pressyanov D
Phys Med; 2019 Jul; 63():79-86. PubMed ID: 31221413
[TBL] [Abstract][Full Text] [Related]
10. Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
Rudat V; Dietz A; Nollert J; Conradt C; Weber KJ; Flentje M; Wannenmacher M
Radiother Oncol; 1999 Dec; 53(3):233-45. PubMed ID: 10660204
[TBL] [Abstract][Full Text] [Related]
11. Prediction of normal tissue response and individualization of doses in radiotherapy.
Guirado D; Ruiz de Almodóvar JM
Phys Med Biol; 2003 Oct; 48(19):3213-23. PubMed ID: 14579861
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer.
Brock WA; Tucker SL; Geara FB; Turesson I; Wike J; Nyman J; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1371-9. PubMed ID: 7635777
[TBL] [Abstract][Full Text] [Related]
13. Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual?
Haikonen J; Rantanen V; Pekkola K; Kulmala J; Grénman R
Int J Cancer; 2003 Mar; 103(6):784-8. PubMed ID: 12516099
[TBL] [Abstract][Full Text] [Related]
14. "SABER": A new software tool for radiotherapy treatment plan evaluation.
Zhao B; Joiner MC; Orton CG; Burmeister J
Med Phys; 2010 Nov; 37(11):5586-92. PubMed ID: 21158270
[TBL] [Abstract][Full Text] [Related]
15. Normal tissue radiosensitivity in breast cancer patients.
Ramsay J; Birrell G
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):339-44. PubMed ID: 7836087
[TBL] [Abstract][Full Text] [Related]
16. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitivity of dermal and tumor fibroblasts derived from the same patient.
Honkanen J; Rantanen V; Kulmala J; Grénman R; Klemi P; Pekkola K
J Cancer Res Clin Oncol; 1998; 124(8):415-20. PubMed ID: 9750017
[TBL] [Abstract][Full Text] [Related]
18. Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors.
Alsbeih G; Malone S; Lochrin C; Girard A; Fertil B; Raaphorst GP
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):143-52. PubMed ID: 10656386
[TBL] [Abstract][Full Text] [Related]
19. Robust dose-painting-by-numbers vs. nonselective dose escalation for non-small cell lung cancer patients.
Petit SF; Breedveld S; Unkelbach J; den Hertog D; Balvert M
Med Phys; 2021 Jun; 48(6):3096-3108. PubMed ID: 33721350
[TBL] [Abstract][Full Text] [Related]
20. Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data.
Levegrün S; Jackson A; Zelefsky MJ; Skwarchuk MW; Venkatraman ES; Schlegel W; Fuks Z; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1064-80. PubMed ID: 11704332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
